Table 1.
Clinical information of 522 TCGA-LUAD patients.
| Variables | Statistics |
|---|---|
| Gender | |
| Male (%) | 242 (46.4%) |
| Female (%) | 280 (53.6%) |
| Age | |
| 80~89 (%) | 30 (5.8%) |
| 70~79 (%) | 150 (28.7%) |
| 60~69 (%) | 146 (28.0%) |
| 50~59 (%) | 83 (16.0%) |
| 40~49 (%) | 25 (4.8%) |
| 30~39 (%) | 2 (0.4%) |
| Not reported (%) | 86 (16.3%) |
| Race | |
| White (%) | 393 (75.3%) |
| Black or African American (%) | 53 (10.2%) |
| Asian (%) | 8 (1.5%) |
| American Indian or Alaska native (%) | 1 (0.2%) |
| Not reported (%) | 67 (12.9%) |
| Status | |
| Alive (%) | 334 (64.0%) |
| Dead (%) | 188 (36.0%) |
| Tumor stage | |
| I (%) | 279 (53.4%) |
| II (%) | 124 (23.8%) |
| III (%) | 85 (16.3%) |
| IV (%) | 26 (5.0%) |
| Not reported (%) | 8 (1.5%) |
LUAD: lung adenocarcinoma.